On the Problem of Differential Diagnosis of Inflammatory and Functional Bowel Diseases

I.Ya. Budzak

Abstract


The paper describes the problems of differential diagnosis of inflammatory (ulcerative colitis, Crohn’s disease) and functional (irritable bowel syndrome) disease of the intestine. The necessity of such differential diagnosis in certain categories of patients was noted. The possibilities of instrumental and laboratory methods of study are shown. Particular attention is paid to the definition of fecal tests — calprotectin and lactoferrin. An analysis of the studies of their information content has been carried out.


Keywords


irritable bowel syndrome; ulcerative colitis; Crohn’s disease; differential diagnosis; calprotectin; lactoferrin

References


Звягинцева Т.Д. Синдром раздраженного кишечника: современные аспекты диагностики и лечения / Т.Д. Звягинцева // Здоров’я України. — 2007. — № 4. — С. 59.

Степанов Ю.М. Реалии и перспективы в диагностике заболеваний кишечника / Ю.М. Степанов, Н.С. Федорова // Сучасна гастроентерологія. — 2010. — № 1. — С. 109-114.

Степанов Ю.М. Содержание фекального кальпротектина у больных хроническими воспалительными заболеваниями кишечника / Ю.М. Степанов, Н.С. Федорова // Сучасна гастроентерологія. — 2010. — № 2. — С. 44-48.

Consensus statement on Crohn’s disease // Materials of 14th ECCO Educational Workshop. — Donetsk, 2010. — 80 р.

Consensus statement on ulcerative colitis // Materials of 14th ECCO Educational Workshop. — Donetsk, 2010. — 76 р.

Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology / S. Dolwani, M. Metzner, J.J. Wassell [et al.] // Aliment. Pharmacol. Ther. — 2004. — 20 (6). — 615-21.

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse / J.P. Gisbert, F. Bermejo, J.L. Perez-Calle [et al.] // Inflamm. Bowel Dis. — 2009. — Vol. 15. — Р. 1190-1198.

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices / J. Langhorst, S. Elsenbruch, J. Koelzer [et al.] // Am. J. Gastroenterol. — 2008. — Vol. 103 (1). — Р. 162-9.

Rome III: the functional gastrointestinal disorders. — 3rd ed. / G.F. Longstreth, W.G. Thompson, W.D. Chey [et al.] // McLean VA: Degnon, 2006. — Р. 487-555.

Biomarkers in the management of ulcerative colitis: a brief review / I. Masoodi, B.M. Tijjani, H. Wani [et al.] // Ger. Med. Sci. — 2011. — 16. — 9.

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome / C.M. Otten, L. Kok, B.J. Witteman [ et al.] // Clin. Chem. Lab. Med. — 2008. — 46 (9). — 1275-80.

World Gastroenterology Organisation Global Guideline / Quigley E., Fried M., Gwee K.A. [et al.] // Irritable bowel syndrome: a global perspective. — 2009. — 32 р.

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein / A.G. Roseth, E. Aadland, J. Jahnsen, N. Raknerud // Digestion. — 1997. —58 (2). — 176-80.

Silberer H. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome / H. Silberer, B. Kuppers, O. Mickisch // Clin. Lab. — 2005. — 51 (3-4). — 117-26.

Smith L.A. Utility of faecal calprotectin analysis in adult inflammatory bowel disease / L.A. Smith, D.R. Gaya // World J. Gastroenterol. — 2012. — 14, 18 (46). — 6782-9.

A simple method for assessing intestinal inflammation in Crohn´s disease / J. Tibble, K. Teahon, B. Thjodleifsson [ et al.] // Gut. — 2000. — 47 (4). — 506-13.




DOI: https://doi.org/10.22141/2308-2097.2.48.2013.86161

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru